Chris Toth, president, global commercial and field operations for Varian, takes a tour of Varian’s new product introductions and major initiatives highlighted at ASTRO 2017. These include:
• The Halcyon system, a new platform for cancer treatment that simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT). Halcyon is a powerfully intuitive platform designed to help improve and strengthen the fight against cancer and enable access to high quality care anywhere in the world.
• The 360 Oncology care management platform, designed to integrate and coordinate patient care across the entire treatment and post-treatment journey. 360 Oncology brings together in a single platform, radiation, medical and surgical oncology, social services, primary care physicians, as well as the patient, to facilitate true collaboration and coordination.
• The latest release of Varian’s Eclipse treatment planning software, incorporating both Multi-Criteria Optimization (MCO) and Graphics Processing Unit (GPU) Support. MCO enables planners to look at tradeoffs in a treatment plan when different clinical criteria are varied, greatly enhancing control over optimization. GPU support decreases the dose calculation and inverse planning optimization times, providing a significant leap forward in speed.
• HyperArc high definition radiotherapy, technology that unlocks the potential of non-coplanar treatment strategies to usher in a new era of precision in the delivery of stereotactic radiosurgery (SRS).
For more information: www.varian.com